Literature DB >> 16870997

Diagnostic approach and management of Lynch syndrome (hereditary nonpolyposis colorectal carcinoma): a guide for clinicians.

Yvonne M C Hendriks1, Andrea E de Jong, Hans Morreau, Carli M J Tops, Hans F Vasen, Juul Th Wijnen, Martijn H Breuning, Annette H J T Bröcker-Vriends.   

Abstract

ABSTRACT diagnostic workup of familial colorectal cancer is an elaborate and time consuming process in which the family and several medical specialists closely collaborate. However, establishing a diagnosis can be very rewarding. If a mutation is detected in the family, a satisfactory explanation can be provided for an accumulation of tumors at young age, and often of untimely death. Appropriate presymptomatic testing can be offered to reduce mortality among at-risk family members, and relatives not at risk can avoid uncertainty and needlessly intensive surveillance. We show the differential diagnostic considerations when an individual with a family history of colorectal carcinoma is encountered, with emphasis on Lynch syndrome (Hereditary Nonpolyposis Colorectal Carcinoma [HNPCC]). Practical recommendations for laboratory workup of suspected Lynch syndrome, including analysis of tumor tissue by microsatellite instability analysis and immunohistochemistry, and germline DNA analysis are given. Furthermore, the clinical management after a molecular diagnosis has been made is described. The diagnostic scheme presented here allows efficient and effective analysis of colorectal carcinoma cases with (suspected) Lynch syndrome, making optimal use of currently available technology.

Entities:  

Mesh:

Year:  2006        PMID: 16870997     DOI: 10.3322/canjclin.56.4.213

Source DB:  PubMed          Journal:  CA Cancer J Clin        ISSN: 0007-9235            Impact factor:   508.702


  46 in total

Review 1.  Microsatellite alteration in multiple primary lung cancer.

Authors:  Cheng Shen; Xin Wang; Long Tian; Guowei Che
Journal:  J Thorac Dis       Date:  2014-10       Impact factor: 2.895

2.  Familial gastric cancer: update for practice management.

Authors:  Giovanni Corso; Daniele Marrelli; Franco Roviello
Journal:  Fam Cancer       Date:  2011-06       Impact factor: 2.375

3.  Novel MLH1 frameshift mutation in an extended hereditary nonpolyposis colorectal cancer family.

Authors:  Tanya-Kirilova Kadiyska; Radka-Petrova Kaneva; Dimitar-Georgiev Nedin; Alexandrina-Borisova Alexandrova; Antonina-Todorova Gegova; Stoyan-Ganchev Lalchev; Tatyana Christova; Vanio-Ivanov Mitev; Juergen Horst; Nadja Bogdanova; Ivo-Marinov Kremensky
Journal:  World J Gastroenterol       Date:  2006-12-28       Impact factor: 5.742

4.  MSH3 mediates sensitization of colorectal cancer cells to cisplatin, oxaliplatin, and a poly(ADP-ribose) polymerase inhibitor.

Authors:  Masanobu Takahashi; Minoru Koi; Francesc Balaguer; C Richard Boland; Ajay Goel
Journal:  J Biol Chem       Date:  2011-02-01       Impact factor: 5.157

Review 5.  Familial colorectal cancer type X: the other half of hereditary nonpolyposis colon cancer syndrome.

Authors:  Noralane M Lindor
Journal:  Surg Oncol Clin N Am       Date:  2009-10       Impact factor: 3.495

6.  Barriers to and motivations for physician referral of patients to cancer genetics clinics.

Authors:  Carrie F Prochniak; Lisa J Martin; Erin M Miller; Sara C Knapke
Journal:  J Genet Couns       Date:  2011-08-13       Impact factor: 2.537

7.  Mutation spectrum in HNPCC in the Israeli population.

Authors:  Yael Goldberg; Rinnat M Porat; Inbal Kedar; Chen Shochat; Michal Sagi; Avital Eilat; Suzan Mendelson; Tamar Hamburger; Aviram Nissan; Ayala Hubert; Luna Kadouri; Eli Pikarski; Israela Lerer; Dvorah Abeliovich; Dani Bercovich; Tamar Peretz
Journal:  Fam Cancer       Date:  2008-04-04       Impact factor: 2.375

Review 8.  Current hypotheses on how microsatellite instability leads to enhanced survival of Lynch Syndrome patients.

Authors:  Kristen M Drescher; Poonam Sharma; Henry T Lynch
Journal:  Clin Dev Immunol       Date:  2010-06-10

9.  Fas ligand expression in lynch syndrome-associated colorectal tumours.

Authors:  Jan J Koornstra; Steven de Jong; Wietske Boersma-van Eck; Nynke Zwart; Harry Hollema; Elisabeth G E de Vries; Jan H Kleibeuker
Journal:  Pathol Oncol Res       Date:  2009-09       Impact factor: 3.201

10.  Performance of clinical guidelines compared with molecular tumour screening methods in identifying possible Lynch syndrome among colorectal cancer patients: a Norwegian population-based study.

Authors:  G Tranø; W Sjursen; H H Wasmuth; E Hofsli; L J Vatten
Journal:  Br J Cancer       Date:  2010-01-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.